The current novel therapeutic regimens for Clostridium difficile infection (CDI) and the potentials of Traditional Chinese Medicine in treatment of CDI
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The current novel therapeutic regimens for Clostridium difficile infection (CDI) and the potentials of Traditional Chinese Medicine in treatment of CDI
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN MICROBIOLOGY
Volume 45, Issue 5-6, Pages 729-742
Publisher
Informa UK Limited
Online
2019-12-14
DOI
10.1080/1040841x.2019.1700905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
- (2019) Wan-li Zhang et al. ACTA PHARMACOLOGICA SINICA
- Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
- (2018) Erik R Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection
- (2018) Tao Zuo et al. Nature Communications
- Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
- (2018) Xiaoyan Wei et al. Scientific Reports
- Structural modulation of gut microbiota during alleviation of antibiotic-associated diarrhea with herbal formula
- (2017) Weijie Lv et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Bezlotoxumab and Recurrent Clostridium difficile Infection
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
- (2017) Wesley D. Kufel et al. PHARMACOTHERAPY
- Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease
- (2017) Qin Feng et al. Oncotarget
- Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
- (2016) Colleen R. Kelly et al. ANNALS OF INTERNAL MEDICINE
- Dose-response effect of berberine on bile acid profile and gut microbiota in mice
- (2016) Ying Guo et al. BMC Complementary and Alternative Medicine
- American Ginseng Attenuates Colitis-Associated Colon Carcinogenesis in Mice: Impact on Gut Microbiota and Metabolomics
- (2016) C.-Z. Wang et al. Cancer Prevention Research
- Traditional Chinese Medicine QPYF as Preventive Treatment forClostridium difficileAssociated Diarrhea in a Mouse Model
- (2016) Guo Ya-Nan et al. Evidence-based Complementary and Alternative Medicine
- The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer’s Disease
- (2016) Jianhui Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- The potential mechanism of Bawei Xileisan in the treatment of dextran sulfate sodium-induced ulcerative colitis in mice
- (2016) Juan Wen et al. JOURNAL OF ETHNOPHARMACOLOGY
- Gut microbiota and central nervous system development
- (2016) Nicola Principi et al. JOURNAL OF INFECTION
- Chronic rhein treatment improves recognition memory in high-fat diet-induced obese male mice
- (2016) Sen Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- CST, an Herbal Formula, Exerts Anti-Obesity Effects through Brain-Gut-Adipose Tissue Axis Modulation in High-Fat Diet Fed Mice
- (2016) AbuZar Ansari et al. MOLECULES
- The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
- (2016) Katarzyna Winek et al. Neurotherapeutics
- Daesiho-Tang Is an Effective Herbal Formulation in Attenuation of Obesity in Mice through Alteration of Gene Expression and Modulation of Intestinal Microbiota
- (2016) Ahtesham Hussain et al. PLoS One
- Resveratrol Attenuates Trimethylamine- N -Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
- (2016) Ming-liang Chen et al. mBio
- Berberine Blocks the Relapse of Clostridium difficile Infection in C57BL/6 Mice after Standard Vancomycin Treatment
- (2015) Zhi Lv et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interactions between traditional Chinese medicine and western drugs in Taiwan: A population-based study
- (2015) Kuan Chen Chen et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Ganoderma lucidum, a new prebiotic agent to treat obesity?
- (2015) Nathalie M. Delzenne et al. Nature Reviews Gastroenterology & Hepatology
- Burden of Clostridium difficile Infection in the United States
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota
- (2015) Chih-Jung Chang et al. Nature Communications
- Rehmannia glutinosa reduced waist circumferences of Korean obese women possibly through modulation of gut microbiota
- (2015) Kyungsun Han et al. Food & Function
- Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection
- (2015) Alexa Weingarden et al. Microbiome
- Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
- (2015) Xu Zhang et al. Scientific Reports
- The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial
- (2014) Sin Ji Lee et al. CLINICAL NUTRITION
- Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
- (2014) Zhiyong Yang et al. INFECTION AND IMMUNITY
- Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula
- (2014) Jia Xu et al. ISME Journal
- Mechanism of Action and Epitopes ofClostridium difficileToxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
- (2014) Peter Orth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection
- (2014) Giovanni Cammarota et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Berberine Enhances the Antibacterial Activity of Selected Antibiotics against Coagulase-Negative Staphylococcus Strains in Vitro
- (2014) Robert Wojtyczka et al. MOLECULES
- Traditional Chinese medication for cardiovascular disease
- (2014) Pan-Pan Hao et al. Nature Reviews Cardiology
- Flos Lonicera Ameliorates Obesity and Associated Endotoxemia in Rats through Modulation of Gut Permeability and Intestinal Microbiota
- (2014) Jing-Hua Wang et al. PLoS One
- Combination of symptoms, syndrome and disease: Treatment of refractory diabetic gastroparesis
- (2014) Jun-Ling Li WORLD JOURNAL OF GASTROENTEROLOGY
- Recovery of the Gut Microbiome following Fecal Microbiota Transplantation
- (2014) A. M. Seekatz et al. mBio
- Microbiome Data Distinguish Patients with Clostridium difficile Infection and Non-C. difficile-Associated Diarrhea from Healthy Controls
- (2014) A. M. Schubert et al. mBio
- Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
- (2014) Vijay Shankar et al. Microbiome
- Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection
- (2013) Alexa R. Weingarden et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Fecal microbiota transplantation for Clostridium difficile infection
- (2013) Andrea Lo Vecchio et al. CURRENT OPINION IN GASTROENTEROLOGY
- Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment ofClostridium difficileinfections
- (2013) Melinda M Soriano et al. Expert Review of Anti-Infective Therapy
- In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin
- (2013) J. A. Leeds et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
- (2013) Claudia Slimings et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
- (2013) V. C. Antharam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula
- (2013) Xiaochen Yin et al. SYSTEMATIC AND APPLIED MICROBIOLOGY
- Antimicrobial-Resistant Strains of Clostridium difficile from North America
- (2012) Fred C. Tenover et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin
- (2012) Fiona Fouhy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin Failures in Recurrent Clostridium difficile Infection: A Problem of Timing
- (2012) R. Orenstein CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
- (2012) Irina Artsimovitch et al. CLINICAL INFECTIOUS DISEASES
- Clostridium difficile Carriage in Healthy Infants in the Community: A Potential Reservoir for Pathogenic Strains
- (2012) C. Rousseau et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- Syndrome differentiation in modern research of traditional Chinese medicine
- (2012) Miao Jiang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Chronic fatigue syndrome, the immune system and viral infection
- (2011) A.S. Bansal et al. BRAIN BEHAVIOR AND IMMUNITY
- Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of NosocomialClostridum difficile–Associated Disease
- (2010) Amee R. Manges et al. JOURNAL OF INFECTIOUS DISEASES
- A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
- (2010) G. W. Tannock et al. MICROBIOLOGY-SGM
- Structural organization of the functional domains of Clostridium difficile toxins A and B
- (2010) R. N. Pruitt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile
- (2010) Jordi M. Lanis et al. PLoS Pathogens
- Intestinal microflora molecular markers of spleen-deficient rats and evaluation of traditional Chinese drugs
- (2009) Ying Peng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular and Clinical Characteristics ofClostridium difficileInfection in a University Hospital in Shanghai, China
- (2008) Haihui Huang et al. CLINICAL INFECTIOUS DISEASES
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
- (2008) K.W. Garey et al. JOURNAL OF HOSPITAL INFECTION
- Chinese Medicine and Its Modernization Demands
- (2007) Wei-Feng Li et al. ARCHIVES OF MEDICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started